Archive for September, 2009
« Previous Entries Next Entries »Shortage of Tamiflu seen nationwide.
Wednesday, September 23rd, 2009The Tennessean (9/23, Sanchez) reports, “Public demand for” Tamiflu (oseltamivir) “has caused a shortage of the children’s dosage” nationwide, and some pharmacies “have run out of Tamiflu in the liquid form.” The Tennessean notes, “Until more liquid prescription can be manufactured, pharmacists must convert the adult dosage capsules into a liquid [...]
Researchers say statins may benefit patients with high levels of inflammation.
Wednesday, September 23rd, 2009HealthDay (9/22, Doheny) reported that “statins could be as beneficial for people with acceptable cholesterol readings but high levels of inflammation as they are for those with high cholesterol levels,” according to research published in Circulation: Cardiology Quality and Outcomes. The researchers said that “the efficiency of treating elevated hs-CRP patients [...]
How To Deal With Irritating Nasal Problems
Friday, September 11th, 2009By Dr Elena Douse
Q. My nose is persistently blocked and congested, and I constantly need to blow it. This has been going on for more than a year and decongestants don’t seem to help. I now can’t breathe through my nose at all. Are there any other treatments I can try?
A. It sounds like you [...]
Anti-Aging Renova Continues To Deliver Maximum Results
Friday, September 11th, 2009In 2008, the global anti-aging skincare market approached $15 billion, with 32 percent of U.S. facial skincare product launches boastinga nti-aging claims many over-the-counter products are claiming to achieve comparable benefits as prescription anti-aging treatments. The interest in anti-aging products continues to grow, but FDA-approved prescription products with rigorous efficacy and safety standards are still the [...]
What are wrinkles?
Friday, September 11th, 2009Although wrinkles can signify wisdom, most people nowadays would rather not have them.
Many products and procedures promise to reduce wrinkles. Some do little or nothing (like the products that claim they reduce “the appearance of fine lines,” which means that they don’t reduce the lines themselves). Others can achieve a fair amount of success.
Skin ages [...]
Colleges Raise Birth Control Costs
Friday, September 11th, 2009College women in the western Chicago suburbs and other areas around the country have seen skyrocketing prices in birth control on their campuses over the last year, due to a change in federal law.
The monthly cost of the birth control pill jumped from around $12 to $50, and the cost of the NuvaRing has jumped [...]
AIDS Activists Issue Grades to Drug Companies
Friday, September 11th, 2009Source: NY Times
Merck won the highest grade and Abbott Laboratories flunked in a report card being issued Thursday by a prominent group of AIDS treatment activists after a yearlong study of the actions of nine major pharmaceutical companies to address the contagion in the United States.
Although advances in drug regimens since the 1990s have added [...]
Pills not only answer to erectile dysfunction
Tuesday, September 8th, 2009With all the ads on TV for Viagra, Cialis and similar medications, it would appear that men’s sexual problems can easily be solved with a little blue pill.
But that’s not so, says Dr. Juan Carlos Paredes, founder of the South Beach Clinic in Miami Beach.
Problems with sexual function may indicate an underlying medical problem. Or [...]
High-dose statin monotherapy may reduce cholesterol as well as combining statin with another drug, research suggests.
Wednesday, September 2nd, 2009Source: DIA Daily
High-dose statin monotherapy may reduce cholesterol as well as combining statin with another drug, research suggests.
Bloomberg News (9/1, Pettypiece) reports that “high doses of cholesterol-lowering pills called statins may work just as well as medicines…that combine different types of cholesterol drugs,” according to research published in the Annals of Internal Medicine.
MedPage Today [...]
Diovan reduces cardiovascular events by 45 percent
Wednesday, September 2nd, 2009Data presented yesterday at the European Society of Cardiology (ESC) Congress in Barcelona, Spain, demonstrated that the addition of the angiotensin receptor blocker (ARB) Diovan (valsartan) to a non-ARB-based treatment regimen for high blood pressure provided a significant 45% relative reduction in cardiovascular events.
A total of 3,042 Japanese patients with high blood pressure uncontrolled on [...]
